2-chloroadenosine has been researched along with Lymphoma in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baron, J; Lin, H; Penumalli, V; Rezania, K; Soliven, B; van Besien, K | 1 |
| Caracciolo, F; Cecconi, N; Galimberti, S; Petrini, M; Riccioni, R | 1 |
| Beutler, E; Carson, DA | 1 |
| Mehta, A; Virchis, A | 1 |
| Boehrer, S; Chow, KU; Hoelzer, D; Jantschke, P; Martin, H; Mitrou, PS; Napieralski, S; Pourebrahim, F; Ries, J; Rummel, MJ; Stein, J; Weidmann, E | 1 |
| Piro, LD | 1 |
| Carrera, CJ; Carson, DA; Lotz, M; Piro, LD; Yamanaka, H | 1 |
| Hiramoto-Yoshioka, A; Hirota, Y; Matsuda, A; Minowada, J; Otani, T; Tanaka, S; Ueda, T; Wataya, Y | 1 |
2 review(s) available for 2-chloroadenosine and Lymphoma
| Article | Year |
|---|---|
Myasthenia gravis, an autoimmune manifestation of lymphoma and lymphoproliferative disorders: case reports and review of literature.
Topics: 2-Chloroadenosine; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cyclosporine; Deoxyadenosines; Fatal Outcome; Female; Humans; Lymphoma; Lymphoma, Follicular; Lymphoproliferative Disorders; Male; Middle Aged; Myasthenia Gravis; Paraneoplastic Syndromes, Nervous System; Prednisone; Pyridostigmine Bromide; Recurrence; Remission Induction; Rituximab; Waldenstrom Macroglobulinemia | 2012 |
2-Chlorodeoxyadenosine: hairy cell leukemia takes a surprising turn.
Topics: 2-Chloroadenosine; Apoptosis; Humans; Leukemia; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid; Lymphocytes; Lymphoma | 1993 |
7 other study(ies) available for 2-chloroadenosine and Lymphoma
| Article | Year |
|---|---|
Low dose 2-CdA schedule activity in splenic marginal zone lymphomas.
Topics: 2-Chloroadenosine; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Deoxyadenosines; Female; Humans; Lymphoma; Middle Aged; Splenectomy; Splenic Neoplasms; Survival Analysis; Treatment Outcome | 2003 |
Splenic lymphoma with villous lymphocytes (SLVL) responding to 2-chlorodeoxyadenosine (2-CdA)
Topics: 2-Chloroadenosine; Antimetabolites, Antineoplastic; Deoxyadenosines; Humans; Lymphoma; Splenectomy; Splenic Neoplasms | 1998 |
Induction of apoptosis by 2-chloro-2'deoxyadenosine (2-CdA) alone and in combination with other cytotoxic drugs: synergistic effects on normal and neoplastic lymphocytes by addition of doxorubicin and mitoxantrone.
Topics: 2-Chloroadenosine; Antineoplastic Agents; Apoptosis; Deoxyadenosines; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Humans; Lymphoma; Mitoxantrone; Tumor Cells, Cultured | 2000 |
2-Chlorodeoxyadenosine treatment of lymphoid malignancies.
Topics: 2-Chloroadenosine; Antineoplastic Agents; Cladribine; Deoxyadenosines; Humans; Leukemia; Lymphoma | 1992 |
Lymphoma, hairy-cell leukemia respond to new agents.
Topics: 2-Chloroadenosine; Antibodies, Monoclonal; Deoxyadenosines; Humans; Immunoconjugates; Immunotoxins; Leukemia, Hairy Cell; Lymphoma; Pentostatin; Ricin | 1992 |
Profound toxicity of deoxyadenosine and 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo.
Topics: 2-Chloroadenosine; Cladribine; Deoxyadenosines; DNA Damage; Humans; In Vitro Techniques; Lymphoma; Monocytes; Pentostatin; T-Lymphocytes | 1989 |
The mechanism of 2-chlorodeoxyadenosine-induced cell death.
Topics: 2-Chloroadenosine; Cell Survival; Cladribine; Cycloheximide; Deoxyadenosines; Deoxycytidine; DNA Damage; Humans; Leukemia; Lymphoma; Tumor Cells, Cultured | 1989 |